04.10.2014 Views

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

surround<strong>in</strong>g supplier-<strong>in</strong>duced demand, <strong>the</strong>re should be no fundamental<br />

assumption <strong>in</strong> relation to whe<strong>the</strong>r or not new private hospitals would<br />

lead to large supplier-<strong>in</strong>duced demand effects <strong>in</strong> Ireland.<br />

7.41 In a recent study of supplier-<strong>in</strong>duced demand for medical services <strong>in</strong><br />

Australia, researchers concluded that well-targeted cost conta<strong>in</strong>ment<br />

measures could help to promote cost-effective outcomes <strong>in</strong> medical<br />

provision and restrict <strong>the</strong> effects, if any, of supplier-<strong>in</strong>duced<br />

demand. 145<br />

7.42 Cost-control strategies <strong>in</strong>clude annual budget and reimbursement<br />

limits, price freezes, predeterm<strong>in</strong>ed length-of-stay agreements, and<br />

designation of procedures for day or side-room treatment. 146 These<br />

measures can facilitate demand management by reduc<strong>in</strong>g <strong>the</strong> scope for<br />

demand <strong>in</strong>ducement. 147 PHI firms have a legitimate right to control<br />

<strong>the</strong>ir costs, but <strong>in</strong> a situation where PHI firms, most notably Vhi<br />

<strong>Health</strong>care, have buyer power, controll<strong>in</strong>g costs related to private<br />

hospital procedures can have knock-on effects. 148<br />

An Analytical Framework for Buyer Power<br />

7.43 An economic framework has been developed for <strong>the</strong> UK Office of Fair<br />

Trad<strong>in</strong>g for analys<strong>in</strong>g <strong>the</strong> potential presence of buyer power. 149 It may<br />

be useful to apply this framework to <strong>the</strong> <strong>Irish</strong> PHI market. The<br />

framework is set out as follows:<br />

Table 6: An Analytical Framework for Buyer Power<br />

Questions Relevant evidence <strong>Irish</strong> PHI market<br />

1. Is <strong>the</strong>re significant<br />

buyer power?<br />

(By ‘significant power’ is<br />

meant <strong>the</strong> ability to<br />

have a material effect<br />

on prices set or<br />

negotiated, on<br />

quantities exchanged,<br />

or on <strong>the</strong> viability of<br />

traders at one or more<br />

stages of <strong>the</strong><br />

production/distribution<br />

cycle).<br />

Significant proportion<br />

of <strong>the</strong> product as a<br />

whole purchased by<br />

this firm.<br />

Significant<br />

arrangement of terms<br />

of purchase by this<br />

firm (e.g.: upfront<br />

fees for distribut<strong>in</strong>g a<br />

product, such as<br />

slott<strong>in</strong>g allowances).<br />

Yes. Vhi <strong>Health</strong>care is <strong>the</strong><br />

significantly, <strong>the</strong> biggest<br />

buyer of private healthcare<br />

services.<br />

145 Bickerdyke et al (2002), p.89<br />

146 OECD (2004) p.35<br />

147 Bickerdyke et al (2002), p.91<br />

148 In its 2004 Report, <strong>the</strong> OECD noted that “Vhi imposed cost conta<strong>in</strong>ment practices that, <strong>in</strong> <strong>the</strong> view<br />

of hospitals, hampered productivity improvements”<br />

149 Dobson, Waterson and Chu (1998), p.31<br />

113

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!